- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
Home > Press > REACH Implementation Projects on Nanomaterials (RIP-oN 2&3) - Final Project Reports published by the European Commission: Reports published to develop specific advice on the implementation of REACH for nanomaterials
Final reports have been published from two REACH Implementation Projects on Nanomaterials (RIP-oN 2&3). Commissioned by the JRC's Institute for Health & Consumer Protection, the projects intended to develop specific advice on the implementation of REACH for nanomaterials. The outputs from the projects have been developed over a period of 12-16 months in consultation with a range of stakeholders. The reports have scoped the current state-of-the-science regarding assessment of nanomaterials in the context of REACH, and provide recommendations to the European Commission on how the REACH Guidance on Information Requirements and Chemical Safety Assessment could be further developed to better address nanomaterials.
The RIP-oN 2 project has addressed the REACH information requirements on intrinsic properties of nanomaterials, and the information needed for safety evaluation of nanomaterials. The RIP-oN 3 project has addressed exposure assessments and hazard and risk characterisation for nanomaterials within the REACH context.
The projects were undertaken by a consortium led by SAFENANO at the Institute of Occupational Medicine and involving the European Chemical Industry Council (Cefic), the Nanotechnology Industries Association (NIA), and Soluzioni Informatiche, which brought together internationally renowned experts from disciplines including physical sciences, life sciences, occupational hygiene, and risk assessment.
The final reports can be downloaded from the DG Environment webpage at ec.europa.eu/environment/chemicals/nanotech/index.htm#ripo:n
SAFENANO is Europe's Centre of Excellence on Nanotechnology Hazard and Risk, providing industry, academia and governments with independent authoritative expertise and state-of-the-art facilities to address risk and safety issues.
For more information, please click here
Dr Rob Aitken
SAFENANO Director and Director of Strategic Consulting
+44 (0)131 449 8003
Copyright © Edinburgh, UKIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
News and information
Unusual quantum liquid on crystal surface could inspire future electronics October 22nd, 2016
Nanoparticle vaccinates mice against dengue fever October 21st, 2016
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
New nanomedicine approach aims to improve HIV drug therapies October 24th, 2016
Study finds surface texture of gallium nitride affects cell behavior October 17th, 2016
10 years of SAFENANO at the IOM October 10th, 2016